Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The long-term lung illness asthma requires proper therapy. The asthma products market is vital to the healthcare industry because it supplies these solutions. Asthmatics may use several devices to take their medications, monitor their symptoms, and enhance their quality of life.
The rise of asthma worldwide affects markets. Due to pollution, urbanization, and lifestyle changes, more individuals are being diagnosed with asthma. This has increased demand for enhanced, easy-to-use asthma devices.
Always-improving breathing devices change the market. Smart inhalers, dry powder inhalers, and nebulizers with dosage timers and Bluetooth connectivity are becoming increasingly popular to measure use. Patients have more therapy options with these gadgets.
Products that prioritize user experience, convenience of use, and commitment are emerging. Inhalation devices with clear instructions, practical features, and easy-to-use designs increase patient compliance and help asthmatics manage their asthma daily.
Asthma treatments are becoming more personalized with personalized medication. Healthcare professionals may tailor asthma therapy to each patient since various inhalers function with different drugs.
The market is favoring biotech asthma therapies. Monoclonal antibodies that target particular inflammatory pathways provide severe asthmatics new therapy options, especially those who don't respond to traditional medications.
Telehealth and online patient monitoring are altering asthma treatment. Connected devices allow physicians to remotely monitor patients' inhaler usage, symptoms, and health to intervene fast and reduce in-person visits.
The asthma treatment industry is impacted by worldwide awareness initiatives. Groups and healthcare institutions are educating the public about asthma causes and encouraging early action to enhance asthma management.
The market is largely influenced by breathing product affordability and accessibility. Easy and affordable breathing devices, particularly in underdeveloped countries, are aimed to equalize asthma care and provide access to effective therapies.
Compliance with legislation and quality standards influences the market. Strict regulations ensure asthma devices are safe and effective. These guidelines impact design, manufacturing, and marketing to satisfy quality requirements.
Concerns regarding breathing devices' global impact are growing. Companies are trying to produce greener inhalers due to concerns about throwaway devices' carbon impact and waste.
A distinct market focuses on safe breathing equipment for children with asthma. Asthma devices for kids aim to make taking medication easy and maximize its benefits.
Teaching individuals how to utilize inhalers and educating them helps the market. Healthcare personnel and patient support organizations help asthmatics use their devices appropriately, improving therapy.
Asthma Devices Market Highlights:
Global Asthma Devices Market Overview
Asthma Devices Market Size was valued at USD 4.00 Billion in 2023. The Global Asthma Devices industry is projected to grow from USD 4.21 Billion in 2024 to USD 7.45 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.89% during the forecast period (2024 - 2032).Asthma is a chronic inflammatory lung disease that narrows the airways. Asthma causes recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Mostly, the symptoms associated with asthma are short-lived and can be easily treated. Asthma inhalers are medical devices which deliver medication into the body via the lungs, thereby, treating asthma and chronic obstructive pulmonary disease. Increasing prevalence of asthma is one of the major drivers for the market growth.
According to the World Health Organization in 2017, approximately 235 million people suffered from asthma. Moreover, it was estimated that in 2015, the disease killed approximately 383 million patients around the globe. Additionally, rising healthcare expenditures and increasing awareness fuel the market growth. However, long treatment procedures and low per capita income followed by lack of favorable reimbursement policies in the developing countries will restrain the market growth during the forecast period.
The UK-based medical device company Acurable disclosed this in October 2022, saying it was helped to raise $10.8 million by its lead investor for the round, Kibo Ventures. The firm will use the funding to speed up AcuPebble SA100, which is a home-based sleep diagnostic tool that helps identify and track obstructive sleep apnea cases around the world. Moreover, Acurable would develop new drugs for cardiovascular diseases, asthma and COPD.
Adherium Limited has partnered with Trudell Medical Limited in August 2022 to treat U.S. patients with COPD.
A US$350 million Series A funding round was won by Arteria Therapeutics, a biotechnology company committed to helping asthmatics live normal lives in July of 2022. This money was expected by the company to fund phase 3 trials for a new asthma candidate that is said to have biologic-like efficacy in treating asthma through oral delivery.
Alkem launched Innohaler, a DPI device in March 2022 with an aim of improving comfort living for Asthma and COPD (Chronic Obstructive Pulmonary Disease) patients and narrowing the existing gaps in Asthma care across India. The introduction of this device marks Alkem’s entry into core inhalation treatments where it expects better medication will reach the lungs with every inhalation due to increased patient awareness and adherence program.
Life Wellness Healthcare announced an update on their online store that allows individuals with chronic obstructive pulmonary disease (COPD) be able to reduce their symptoms at home as of January 2022. Payment plans are available when purchasing AirPhysio devices, which are now ready for shipment throughout the United States.
For example, in March 2022, the US Food and Drug Administration approved Symbicort Inhalation Aerosol’s first generic version for treating two common pulmonary conditions, including asthma, among six-year-old and older patients.
For example, a Phase III clinical trial evaluating budesonide/glycopyrronium/formoterol inhalers effectiveness and safety among adults and adolescents who suffer from severe asthma and are inadequately controlled with the standard of care was initiated in March 2021 by AstraZeneca PLC in Mexico and the United States. The trial is expected to be completed in September 2023.
Asthma Devices Market Segment Insights
The global asthma devices market is segmented on the basis of type, technology, and end users.
Asthma Devices Type Insights
On the basis of the type, the market is segmented into inhalers, nebulizers, and others. The inhalers segment is sub-segmented into metered-dose inhalers and dry powder inhalers. The metered-dose inhalers segment, by inhalers, is further categorized into standard pressurized metered-dose inhalers, breath-activated pressurized metered-dose inhalers, metered-dose inhalers with a spacer, and others. The nebulizers segment is sub-segmented into compressor nebulizers, ultrasonic nebulizers, mesh nebulizers, and others.
Asthma Devices Technology Insights
On the basis of technology, the asthma devices market is segmented into manually operated inhaler devices, digitally operated inhaler devices, and others.
Asthma Devices End-User Insights
On the basis of end users, the market is segmented into hospital, clinics, retail pharmacies, and others.
Asthma Devices Regional Insights
The Americas dominate the global asthma devices market owing to a well-developed healthcare sector and huge patient population for asthma diseases. According to the Centres for Disease Control and Prevention, in 2015, approximately, 7.8% of the total population in the U.S. was identified for the presence of asthma. Moreover, changing lifestyle and increasing healthcare expenditure fuels the market growth. Additionally, the presence of global players like Merck & Co., Inc. and Baxter, and others boost market growth during the forecast period.
Europe is the second largest asthma devices market owing to a well-developed healthcare infrastructure and huge patient population. Moreover, government support for research & development and rising healthcare expenditures fuel the market growth. According to a study published in the Asthma Research and Practice journal in 2017, the yearly estimated cost for all the asthmatics per patient is about USD 1,900. Additionally, the presence of the developed economies like the U.K, Germany, and France within the region boosts the market growth.
Asia Pacific is the fastest growing region in the global market due to the presence of a huge patient population and continuously developing economies like India and China. According to a study of the Indian Chest Society in 2015, 300 million people suffered from asthma worldwide and about a tenth of its share is in India. Moreover, as per the Indian Brand Equity Foundation in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.8% and reach USD 280 billion by 2020. Moreover, favorable government policies like reduced excise and customs duty followed by the exemptions in service tax along boosts the market growth.
On the other hand, the Middle East & Africa holds the least share of the global asthma devices market due to the presence of poor economy, especially within the African region. The absence of the developed healthcare sector and stringent government policies restrain the market growth within the African region. Majority of the market within the region is held by the Middle East due to huge healthcare expenditures.
Key players for Asthma Devices Market
- GlaxoSmithKline plc. (Europe)
- Merck & Co., Inc. (U.S.)
- 3M (U.S.)
- Aristopharma Ltd. (Asia Pacific)
- SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific)
- AstraZeneca (Europe)
- Baxter. (U.S.)
- Boehringer Ingelheim GmbH (Europe)
- Koninklijke Philips N.V. (Europe)
Intended Audience
-
Pharmaceutical Companies
-
Biotechnological Institutes
-
Research and Development (R&D) Companies
-
Medical Research Laboratories
-
Market Research and Consulting Service Providers
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
